Table 1.
Characteristics of the studies included in the meta-analysis.
| Author | Year | Type of study | Country | Hospitals | Population | Severity of sepsis | Type of diabetes | Primary outcome | Secondary outcomes | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Length of hospital stay | Acute kidney injury | Respiratory dysfun-ction | |||||||||
| Moss [9] | 2000 | A prospective cohort study | America | 4 | 113 | Septic shock | Not mentioned | In-hospital mortality | No | No | Yes |
| Moutzouri [10] | 2008 | A prospective cohort study | Greece | 1 | 64 | Severe sepsis or septic shock | 2 | In-hospital mortality | No | No | No |
| Stegenga [11] | 2010 | A retrospective cohort study | 11 countries | 164 | 830 | Severe sepsis or septic shock | Not mentioned | mortality at day 28 | Yes | No | No |
| Schuetz [12] | 2011 | A retrospective cohort study | America | 2 | 7754 | All sepsis | Not mentioned | In-hospital mortality | No | No | No |
| Yang [13] | 2011 | A retrospective cohort study | Singapore | 1 | 9221 | All sepsis | 2 | In-hospital mortality | Yes | Yes | Yes |
| Schuetz [14] | 2012 | A prospective cohort study | America | 1 | 1849 | All sepsis | 1+2 | In-hospital mortality | No | No | No |
| Chang [15] | 2012 | A prospective cohort study | China, Taiwan | 1 | 16497 | Severe sepsis or septic shock | 2 | In-hospital mortality | Yes | Yes | Yes |
| Al-Dorzi [16] | 2012 | A retrospective cohort study | Canada, USA and Saudi Arabia | 28 | 8670 | Septic shock | Not mentioned | In-hospital mortality | No | No | No |
| Venot [17] | 2015 | A prospective cohort study | France | 12 | 1064 | Severe sepsis or septic shock | Not mentioned | In-hospital mortality | Yes | Yes | No |
| De Miguel-Yanes [18] | 2015 | A retrospective cohort study | Spain | 95% hospital of Spain | 217280 | All sepsis | 2 | In-hospital mortality | Yes | No | No |